Diagnostics
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
2,070
NCT02911571
PRospective Multiple Myeloma Impact Study
Phase: N/A
Role: Lead Sponsor
Start: Feb 27, 2018
Completion: Sep 1, 2026
NCT04759781
MElanoma Research Lymph Node Prediction Implementation National_001
Start: Aug 25, 2021
Completion: Jun 30, 2029
Loading map...